---
title: Data Use Agreement & Access Instructions
---

!!! warning "Sample Content Only"
    This page includes sample terms and procedures adapted from other registries. Please update all placeholders and ensure your local legal and governance teams review your final version.

# Data Use Agreement (DUA) & Research Data Access

This page outlines the procedures and terms for requesting access to data from the **[Registry Name]**, maintained by **[Registry Organization]**. These policies are designed to ensure secure and ethical use of patient-level registry data.

## ðŸ”‘ How to Request Data

All data requests must include:

- A completed data request form (linked or attached by your registry)
- Proof of IRB submission or approval
- A signed Confidentiality Agreement (template available upon request)
- A detailed list of requested variables or data domains

To initiate a request, contact **[datarequests@yourorganization.org]** or visit our [Data Request Portal](https://yourorg.org/data-portal).

ðŸ• *Standard review time is 3â€“6 months depending on complexity.*

> ðŸ’¡ Note: Industry or commercial requests may follow a separate process. Contact **[industryrequests@yourorganization.org]** for more information.

---

## ðŸ”’ Terms and Conditions

Access is contingent upon full compliance with these data use requirements:

- Only non-identifiable data will be shared unless approved under a Limited Data Set with additional agreements.
- The dataset may only be used for the specific project outlined in your application.
- No attempts to re-identify participants are permitted.
- Data must be stored securely and may not be redistributed.
- Investigators must submit abstracts 7 days and manuscripts 30 days prior to submission for registry review.
- Projects must be completed within 3 years of data access; extensions may be requested.
- Upon study completion, all data files must be destroyed and written confirmation sent to the registry.

ðŸ“ Suggested Acknowledgment Language:  
> â€œThe authors thank [Registry Organization] for providing access to [Registry Name] data for this study. We extend our gratitude to the individuals who contributed data and the participating sites.â€

ðŸ“¢ Suggested Data Availability Statement:  
> â€œData are available upon reasonable request through the [Registry Organization]'s Research Oversight Committee. Contact [datarequests@yourorg.org] for details. Access restrictions apply to protect patient privacy.â€

---

## ðŸ“„ Signature Requirements

The following must be signed and submitted:

- Confidentiality Agreement
- (If applicable) Information Use Agreement (IUA) for Limited Data Sets
- IRB approval letter

The **Principal Investigator (PI)** must be affiliated with the institution responsible for data analysis. Changes in personnel or institution must be reported to **[Registry Organization]**.

---

## Citation

> *Adapted with permission from the Cystic Fibrosis Foundation: CFFPR Data Application and Confidentiality Agreement.*

